Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Terns Pharmaceuticals Inc...

    NASDAQ: TERN · Real-Time Price · USD
    3.70
    0.16 (4.52%)
    At close: Jun 06, 2025, 3:59 PM
    3.73
    0.81%
    After-hours: Jun 06, 2025, 04:56 PM EDT

    Terns Pharmaceuticals Statistics

    Share Statistics

    Terns Pharmaceuticals has 87.34M shares outstanding. The number of shares has increased by 34.97% in one year.

    Shares Outstanding

    n/a
    		 87.34M

    Shares Change (YoY)

    n/a
    		 34.97%

    Shares Change (QoQ)

    n/a
    		 2.78%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 38

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 5.46M, so 6.25% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 5.46M

    Short % of Shares Out

    n/a
    		 6.25%

    Short % of Float

    n/a
    		 6.25%

    Short Ratio (days to cover)

    n/a
    		 6.13

    Valuation Ratios

    The PE ratio is -4.96 and the forward PE ratio is -3.08. Terns Pharmaceuticals's PEG ratio is 0.42.

    PE Ratio

    n/a
    		 -4.96

    Forward PE

    n/a
    		 -3.08

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 18.4

    PB Ratio

    n/a
    		 1.27

    P/FCF Ratio

    n/a
    		 -6.29

    PEG Ratio

    n/a
    		 0.42
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Terns Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 23.14, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 23.14

    Quick Ratio

    n/a
    		 23.14

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 -0.02

    Debt / FCF

    n/a
    		 -0.02

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,505,983.05

    Employee Count

    n/a
    		 59

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 260K

    Effective Tax Rate

    n/a
    		 -0.29%

    Stock Price Statistics

    The stock price has increased by -48.25% in the last 52 weeks. The beta is -0.19, so Terns Pharmaceuticals's price volatility has been lower than the market average.

    Beta

    n/a
    		 -0.19

    52-Week Price Change

    n/a
    		 -48.25%

    50-Day Moving Average

    n/a
    		 2.88

    200-Day Moving Average

    n/a
    		 5.34

    Relative Strength Index (RSI)

    n/a
    		 71.28

    Average Volume (20 Days)

    n/a
    		 1,011,387

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -101.87M

    Net Income

    n/a
    		 -88.85M

    EBITDA

    n/a
    		 -87.7M

    EBIT

    n/a
    		 -88.59M

    Earnings Per Share (EPS)

    n/a
    		 -1.12
    Full Income Statement

    Balance Sheet

    The company has 161.44M in cash and 1.35M in debt, giving a net cash position of 160.09M.

    Cash & Cash Equivalents

    n/a
    		 161.44M

    Total Debt

    n/a
    		 1.35M

    Net Cash

    n/a
    		 160.09M

    Retained Earnings

    n/a
    		 -421.48M

    Total Assets

    n/a
    		 339.31M

    Working Capital

    n/a
    		 326.81M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -70.02M and capital expenditures -42K, giving a free cash flow of -70.06M.

    Operating Cash Flow

    n/a
    		 -70.02M

    Capital Expenditures

    n/a
    		 -42K

    Free Cash Flow

    n/a
    		 -70.06M

    FCF Per Share

    n/a
    		 -0.88
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    TERN does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for TERN is $17.5, which is 373% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $17.5

    Price Target Difference

    n/a
    		 373%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 5
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 10.55

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist